新地(00016.HK)雷霆:「汇玺III」将推出3号价单涉293伙
新地(00016.HK)副董事总经理雷霆在发布会上表示,昨日推售的西南九龙「汇玺III」首轮352伙单位已近乎沽清,将会即日推出3号价单,涉及293伙,大部分以原价加推,只有少部分是轻微加价1至2%。他解释,这批单位的售价较首两张价单为高,主要是由於多属高层及海景单位,会尽快公布销售安排。
至於昨日的买家分布有两成是来自港岛,48%来自九龙,32%来自新界,看到一房及四房单位较受欢迎。而3号价单将会多推一些四房单位。
他表示,最近外围因素令股市表现波动,因此选择买楼保值的人增加,加上联储局宣布减息,亦会加大一些租楼的人的买楼意欲,看到最近销情不错,希望社会亦能够尽快回复平静。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.